Medicine and Dentistry
Pregnancy
100%
Oligonucleotide
100%
Vasoconstriction
100%
CpG Oligodeoxynucleotide
100%
Gestational Hypertension
100%
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
50%
Artery Resistance
33%
Artery
33%
Prostaglandin Synthase
33%
Thromboxane A2
33%
Nitric Oxide Synthase
33%
Cardiovascular System
16%
Bacterial Infection
16%
Pre-Eclampsia
16%
Bacterial DNA
16%
Blood Pressure
16%
Systolic Blood Pressure
16%
DNA Sequence
16%
Premature Labor
16%
Artery Constriction
16%
Pregnancy Complication
16%
Maternal Exposure
16%
Craniofacial Malformation
16%
Keyphrases
Vasoconstriction
100%
CpG ODN
100%
Pregnant Rats
100%
Maternal Hypertension
100%
U46619
37%
CpG DNA
37%
Cyclooxygenase-1 (COX-1)
25%
Thromboxane A2 (TXA2)
25%
Non-pregnant Women
25%
Contractile Response
25%
Mesenteric Resistance Arteries
25%
Resistance Arteries
12%
Bacterial Infection
12%
Blood Pressure
12%
Preeclampsia
12%
Vascular Dysfunction
12%
Cardiovascular Health
12%
Bacterial DNA
12%
Systolic Blood Pressure
12%
DNA Sequencing
12%
Female Rats
12%
Inducible Nitric Oxide Synthase
12%
Immunomodulatory Effect
12%
Day 14
12%
Preterm Birth
12%
Gestational Day
12%
Pregnancy Complications
12%
Nitric Oxide Synthase Inhibition
12%
Unmethylated CpG
12%
Maternal Exposure
12%
Craniofacial Malformations
12%
Emax
12%
Fetal Demise
12%
Biochemistry, Genetics and Molecular Biology
Oligonucleotide
100%
Vasoconstriction
100%
Pregnancy
100%
U46619
100%
Artery Resistance
66%
Cyclooxygenase
66%
Nitric Oxide Synthase
66%
Thromboxane A2
66%
Blood Pressure
33%
DNA Sequence
33%
Systolic Blood Pressure
33%
Artery Constriction
33%
Pharmacology, Toxicology and Pharmaceutical Science
CpG Oligodeoxynucleotide
100%
Maternal Hypertension
100%
Oligonucleotide
100%
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
50%
Prostaglandin Synthase
33%
Thromboxane A2
33%
Nitric Oxide Synthase
33%
Bacterial Infection
16%
Preeclampsia
16%
Premature Labor
16%
Pregnancy Complication
16%
Bacterial DNA
16%
Craniofacial Malformation
16%
Maternal Exposure
16%